Payden & Rygel Quest Diagnostics Inc Transaction History
Payden & Rygel
- $1.21 Billion
- Q2 2025
A detailed history of Payden & Rygel transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Payden & Rygel holds 93,600 shares of DGX stock, worth $12.8 Million. This represents 1.39% of its overall portfolio holdings.
Number of Shares
93,600Holding current value
$12.8 Million% of portfolio
1.39%Shares
1 transactions
Others Institutions Holding DGX
# of Institutions
1,118Shares Held
107MCall Options Held
469KPut Options Held
601K-
Vanguard Group Inc Valley Forge, PA14.2MShares$1.95 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$1.38 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.19MShares$986 Million0.15% of portfolio
-
State Street Corp Boston, MA5.18MShares$711 Million0.03% of portfolio
-
Jpmorgan Chase & CO New York, NY3.77MShares$517 Million0.04% of portfolio
About QUEST DIAGNOSTICS INC
- Ticker DGX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 113,887,000
- Market Cap $15.6B
- Description
- Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...